Engineering

JanOne

$5.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+1.84%) Today
-$0.01 (-0.18%) As of 9:03 PM UTC after-hours

Why Robinhood?

You can buy or sell JanOne and other stocks, options, and ETFs commission-free!

About JAN

JanOne, Inc. focuses on developing treatments for diseases that cause severe pain. It aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The firm also provides solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JanOne is dedicated to funding resources toward innovation, technology, and education for PAD, associated vascular conditions and neuropathic pain. The company continues to operate its legacy businesses under their current brand names, which are undergoing review to determine appropriate strategic alternatives. JanOne was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV. The listed name for JAN is JanOne Inc. Common Stock (NV).

CEO
Tony Isaac
Employees
208
Headquarters
Las Vegas, Nevada
Founded
1976
Market Cap
9.69M
Price-Earnings Ratio
Dividend Yield
Average Volume
199.85K
High Today
$5.79
Low Today
$5.36
Open Price
$5.56
Volume
200.06K
52 Week High
$9.10
52 Week Low
$2.01

Collections

JAN Earnings

-$2.32
-$1.55
-$0.77
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Apr 5, Pre-Market

You May Also Like

IWX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure